Showing results (441-450 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensusPeter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.Neuro-Oncology|June 15, 2022
Diversity within the neurosurgical oncology workforce in the United States: A cross-sectional study with proposed strategies to pave the path forwardZerubabbel Ketema Asfaw, Analiz Rodriguez, Tiffany Renee Hodges, et al.Neuro-Oncology|January 18, 2014
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic toolLorea Manterola, Elizabeth Guruceaga, Jaime Gállego Pérez-Larraya, et al.Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.Neuro-Oncology|May 22, 2014
The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010Quinn T Ostrom, Yanwen Chen, Peter M de Blank, et al.Neuro-Oncology|June 4, 2014
Incidence of brain metastasis at initial presentation of lung cancerJ Lee Villano, Eric B Durbin, Chris Normandeau, et al.Neuro-Oncology|June 9, 2014
Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade gliomaTamara Z Vern-Gross, Jane E Schreiber, Alberto Broniscer, et al.Neuro-Oncology|November 8, 2012
Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastomaAndrea Schäfer, Julian Teufel, Florian Ringel, et al.Neuro-Oncology|March 28, 2015
Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewJohan A F Koekkoek, Melissa Kerkhof, Linda Dirven, et al.Neuro-Oncology|March 10, 2015
Polymeric drug delivery for the treatment of glioblastomaScott D Wait, Roshan S Prabhu, Stuart H Burri, et al.Pageof 315